Developer docs
API playgroundTry for free, no card

Search company profiles

Collaborative Drug Discovery

Full company profile

uuid0005rzk

Namestring
Collaborative Drug Discovery
Legal namestring
Collaborative Drug Discovery, Inc.
Company typeenum
Private
Founded yearint
2004
Descriptiontext

Collaborative Drug Discovery (CDD), founded in 2004 and headquartered in Burlingame, California, operates a hosted SaaS platform called CDD Vault that manages biological and chemical data for drug discovery research. The platform provides web-based scientific data management combining entity registration (small molecules, biologics, peptides, nucleic acids, mixtures), assay informatics, electronic lab notebook (ELN) functionality, inventory tracking, dose-response curve analysis, and visualization tools. Modular add-ons extend the core platform with AI capabilities, automation for instrument connectivity, and specialized biologics support. CDD Vault is differentiated by domain specialization for drug discovery, FAIR data principles compliance, REST API access, and a 90-minute onboarding-to-proficiency window.

The company serves a diversified customer base spanning biotechnology and pharmaceutical firms, contract research organizations, academic medical centers, agritech companies, and non-profit research funders, with notable logos including the Bill & Melinda Gates Foundation, Weill Cornell Medicine, Indiana University School of Medicine, X-Chem, Jubilant Biosys, Standigm, Plexium, and MoA Technology. Revenue is generated through quote-based annual SaaS subscriptions on a fully hosted, secure platform with a PLG motion through free Public Access data registration and a sales-led motion via dedicated US and UK enterprise sales teams.

CDD has executed a multi-quarter product cadence through 2025-2026, including AI+ and Curves module updates, Zero-Click Inference, a Visualization Workspace release, Registration Blueprints for multi-entity support, and a strategically significant May 2026 integration of Eli Lilly's TuneLab AI/ML platform that gives biotech customers access to Lilly-trained ADMET models via federated learning. The company operates from Burlingame, a Washington DC office, and a UK regional headquarters in Cambridge, supporting multi-language access across eight languages and a global customer footprint.

Short descriptiontext

Collaborative Drug Discovery operates CDD Vault, a hosted SaaS platform that manages biological and chemical data for drug discovery research. It serves biotech, pharma, CROs, and academic institutions globally through subscription-based modular data management and AI tools.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersBurlingame, United States
HQ citystring
Burlingame
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
drug discovery informatics, electronic lab notebook, scientific data management, biological chemical database, preclinical research software
NAICS code1 code
  • Research and Development in the Physical, Engineering, and Life Sciences54171
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Drug Discovery Informatics Software
Social media profiles1 record
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model1 record
1Software Subscription (CDD Vault)
TypeSubscription Recurring
Description

CDD Vault operates as a SaaS platform with subscription-based pricing. The platform is described as fully hosted and secure, with subscription fees varying based on functionality tiers and usage levels. Multiple modules available including ELN, Inventory, Curves, AI, and Automation add-ons.

collaborativedrug.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Infrastructure, Marketing or Sales, Operations
Pricing details1 tier
1CDD Vault platform with modular add-ons
ModelSubscriptionBilling cadenceAnnual
Notes

Quote-based pricing not publicly disclosed. Company emphasizes cost-effectiveness vs. competitors. Platform includes core functionality with optional add-ons for ELN, Inventory, Curves, AI, and Automation.

collaborativedrug.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

Collaborative Drug Discovery (CDD) sells CDD Vault, a hosted, web-based scientific data management platform and electronic lab notebook (ELN) purpose-built for drug discovery research. The platform securely registers and tracks chemical and biological entities (small molecules, biologics, peptides, nucleic acids, mixtures), captures experimental assay and activity data, and enables real-time collaboration across organizations. Modular add-ons extend capabilities into ELN, inventory management, dose-response curve fitting, AI/ML-driven lead discovery, and laboratory automation integrations.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Users become proficient in 90 minutes of guided onboarding
+2 more records
Product overview1 text field

CDD Vault is a unified scientific data management and drug discovery informatics platform combining a core platform with modular add-ons. The platform provides web-based collaboration for managing biological and chemical data across research organizations. Core CDD Vault includes entity Registration, Activity tracking, Visualization, and Assays modules. Add-on modules extend capabilities with ELN (Electronic Lab Notebook), Inventory management, Curves for dose-response analysis, AI for machine learning applications, Automation for instrument connectivity, and Biologics support for protein therapeutics. An advanced AI+ module offers enhanced generative AI capabilities. The platform integrates external AI/ML services such as Eli Lilly's TuneLab for ADMET predictions. CDD also offers free Public Access data hosting for community research datasets.

Product and service3 records
1CDD Vault
CategoryScientific Data Management Platform
Description

Core hosted scientific data management platform and electronic lab notebook for drug discovery research. Provides web-based secure registration of chemical and biological entities (small molecules, biologics, peptides, nucleic acids, mixtures), experimental assay capture, activity tracking, visualization, and AI/ML-enabled lead discovery for biotech, pharma, CROs, and academic research organizations.

2CDD Vault AI+
CategoryAI Drug Discovery Module
Description

Advanced AI add-on module offering enhanced machine learning and generative AI capabilities for drug discovery within CDD Vault, including deeper-learning integrations beyond the standard AI module.

3CDD Public Access
CategoryPublic Scientific Data Repository
Description

Free public dataset repository integrated with CDD Vault that hosts validated drug discovery datasets from leading research groups. Includes the SPARK antibiotic discovery program, COVID-19 compound data, malaria screens, and tuberculosis research data, and is fully integrated with CDD Vault for users with accounts.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2026-05-20
Description

Strategic partnership to integrate Eli Lilly's TuneLab AI/ML drug discovery platform into CDD Vault. TuneLab provides predictive ADMET models trained on decades of Lilly research data for in silico property predictions across small molecules and antibody therapeutics. The federated training approach means model accuracy improves as more companies contribute data within the secure CDD Vault environment. TuneLab has grown to over 75 partners across dozens of countries.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Major non-profit funder using CDD Vault for global tuberculosis drug discovery and neglected disease research. CDD has a decade-long commitment to supporting Gates Foundation-funded researchers with data management tools.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Selected CDD Vault to accelerate therapy development for Alzheimer's disease research. Academic partnership for drug discovery data management.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers8 records
TypeDirect peer
Description

Benchling is the most directly comparable cloud-based R&D platform for life sciences, offering ELN, registration, inventory, and workflow tools for biotech and pharma. CDD explicitly positions against Benchling on cost and time-to-value, and the two compete head-to-head for mid-market and enterprise biotech informatics contracts.

TypeDirect peer
Description

Dotmatics (now part of Revvity) is a scientific informatics platform providing ELN, registration, assay analysis, and data visualization for drug discovery. Like CDD, it serves chemistry and biology workflows for pharma and biotech, and is cited by CDD as a direct competitor on cost and ease-of-use dimensions.

TypeDirect peer
Description

IDBS (owned by Danaher) provides the Polar and E-WorkBook ELN platforms for biopharmaceutical R&D, with deep history in process and formulation data. It competes with CDD for biotech informatics spend, particularly with larger pharma customers and process development workflows.

TypeDirect peer
Description

LabArchives is a SaaS ELN widely used in academic and research institutions, including many NIH-funded groups that CDD also serves. It competes with CDD's ELN module, particularly in academic settings where budget and NIH DMS Policy compliance drive platform choice.

TypeDirect peer
Description

LabVantage is a LIMS/ELN provider serving pharmaceutical, biotech, and academic labs with sample tracking and laboratory workflow management. It competes with CDD Vault's inventory and assay management modules for lab informatics contracts.

TypeDirect peer
Description

Mestrelab provides chemistry-focused informatics software including Mnova for NMR/LC-MS analysis and chemical registration tools. It overlaps with CDD's chemistry registration and assay analysis capabilities, particularly for medicinal chemistry customers.

TypeDirect peer
Description

ChemAxon provides cheminformatics software (JChem, Marvin, Compound Registration) for chemical structure management, search, and analysis. It serves similar drug discovery and chemistry R&D customers as CDD and competes on chemical registration and structure-based data management.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses1 record

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers11 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
Yes

Docs URL, Description

Integration1 record

Each record includes

Title, Type, Description, Source

AI capability6 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Collaborative Drug Discovery

Drug Discovery Informatics Softwarecollaborativedrug.com

Collaborative Drug Discovery operates CDD Vault, a hosted SaaS platform that manages biological and chemical data for drug discovery research. It serves biotech, pharma, CROs, and academic institutions globally through subscription-based modular data management and AI tools.

What Collaborative Drug Discovery does

Collaborative Drug Discovery (CDD), founded in 2004 and headquartered in Burlingame, California, operates a hosted SaaS platform called CDD Vault that manages biological and chemical data for drug discovery research. The platform provides web-based scientific data management combining entity registration (small molecules, biologics, peptides, nucleic acids, mixtures), assay informatics, electronic lab notebook (ELN) functionality, inventory tracking, dose-response curve analysis, and visualization tools. Modular add-ons extend the core platform with AI capabilities, automation for instrument connectivity, and specialized biologics support. CDD Vault is differentiated by domain specialization for drug discovery, FAIR data principles compliance, REST API access, and a 90-minute onboarding-to-proficiency window.

The company serves a diversified customer base spanning biotechnology and pharmaceutical firms, contract research organizations, academic medical centers, agritech companies, and non-profit research funders, with notable logos including the Bill & Melinda Gates Foundation, Weill Cornell Medicine, Indiana University School of Medicine, X-Chem, Jubilant Biosys, Standigm, Plexium, and MoA Technology. Revenue is generated through quote-based annual SaaS subscriptions on a fully hosted, secure platform with a PLG motion through free Public Access data registration and a sales-led motion via dedicated US and UK enterprise sales teams.

CDD has executed a multi-quarter product cadence through 2025-2026, including AI+ and Curves module updates, Zero-Click Inference, a Visualization Workspace release, Registration Blueprints for multi-entity support, and a strategically significant May 2026 integration of Eli Lilly's TuneLab AI/ML platform that gives biotech customers access to Lilly-trained ADMET models via federated learning. The company operates from Burlingame, a Washington DC office, and a UK regional headquarters in Cambridge, supporting multi-language access across eight languages and a global customer footprint.

Collaborative Drug Discovery firmographics

Firmographics
Name
Collaborative Drug Discovery
Legal name
Collaborative Drug Discovery, Inc.
Website
https://collaborativedrug.com
Company type
Private
Founded year
2004
Operating status
Operating
Headcount range
51–100 employees
Short description
Collaborative Drug Discovery operates CDD Vault, a hosted SaaS platform that manages biological and chemical data for drug discovery research. It serves biotech, pharma, CROs, and academic institutions globally through subscription-based modular data management and AI tools.
Ownership category
akta.pro rank

Where Collaborative Drug Discovery is headquartered

Location

Headquarters

HQ city
Burlingame
HQ country
United States
HQ region
North America

Offices3 records

Markets served

Collaborative Drug Discovery business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Infrastructure, Marketing or Sales, Operations

Revenue model

  1. Software Subscription (CDD Vault): CDD Vault operates as a SaaS platform with subscription-based pricing. The platform is described as fully hosted and secure, with subscription fees varying based on functionality tiers and usage levels. Multiple modules available including ELN, Inventory, Curves, AI, and Automation add-ons.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualCDD Vault platform with modular add-ons

Go-to-market motion3 records

Distribution channels4 records

Marketing channels7 records

Collaborative Drug Discovery product offering

Product offering

Core offering

Collaborative Drug Discovery (CDD) sells CDD Vault, a hosted, web-based scientific data management platform and electronic lab notebook (ELN) purpose-built for drug discovery research. The platform securely registers and tracks chemical and biological entities (small molecules, biologics, peptides, nucleic acids, mixtures), captures experimental assay and activity data, and enables real-time collaboration across organizations. Modular add-ons extend capabilities into ELN, inventory management, dose-response curve fitting, AI/ML-driven lead discovery, and laboratory automation integrations.

Product overview

CDD Vault is a unified scientific data management and drug discovery informatics platform combining a core platform with modular add-ons. The platform provides web-based collaboration for managing biological and chemical data across research organizations. Core CDD Vault includes entity Registration, Activity tracking, Visualization, and Assays modules. Add-on modules extend capabilities with ELN (Electronic Lab Notebook), Inventory management, Curves for dose-response analysis, AI for machine learning applications, Automation for instrument connectivity, and Biologics support for protein therapeutics. An advanced AI+ module offers enhanced generative AI capabilities. The platform integrates external AI/ML services such as Eli Lilly's TuneLab for ADMET predictions. CDD also offers free Public Access data hosting for community research datasets.

Differentiator

Problem solved

Functional benefit

Products and services

  • CDD Vault Core hosted scientific data management platform and electronic lab notebook for drug discovery research. Provides web-based secure registration of chemical and biological entities (small molecules, biologics, peptides, nucleic acids, mixtures), experimental assay capture, activity tracking, visualization, and AI/ML-enabled lead discovery for biotech, pharma, CROs, and academic research organizations.
  • CDD Vault AI+ Advanced AI add-on module offering enhanced machine learning and generative AI capabilities for drug discovery within CDD Vault, including deeper-learning integrations beyond the standard AI module.
  • CDD Public Access Free public dataset repository integrated with CDD Vault that hosts validated drug discovery datasets from leading research groups. Includes the SPARK antibiotic discovery program, COVID-19 compound data, malaria screens, and tuberculosis research data, and is fully integrated with CDD Vault for users with accounts.

Quantifiable outcome

  • Users become proficient in 90 minutes of guided onboarding
  • +2 more outcomes

Companies that use Collaborative Drug Discovery

Customer profile

Named customers11 records

Segments6 records

Ideal customer profiles3 records

Collaborative Drug Discovery technology and API

Technology

Technology focussed Yes

API detail

Has API
Yes
API docs
API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability6 records

Feature8 records

Collaborative Drug Discovery partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core and minor.

  • Eli LillycoreTechnology or Integration · 20 May 2026Strategic partnership to integrate Eli Lilly's TuneLab AI/ML drug discovery platform into CDD Vault. TuneLab provides predictive ADMET models trained on decades of Lilly research data for in silico property predictions across small molecules and antibody therapeutics. The federated training approach means model accuracy improves as more companies contribute data within the secure CDD Vault environment. TuneLab has grown to over 75 partners across dozens of countries.
  • Bill and Melinda Gates FoundationcoreStrategic or Co-development PartnerMajor non-profit funder using CDD Vault for global tuberculosis drug discovery and neglected disease research. CDD has a decade-long commitment to supporting Gates Foundation-funded researchers with data management tools.
  • Indiana University School of MedicineminorStrategic or Co-development PartnerSelected CDD Vault to accelerate therapy development for Alzheimer's disease research. Academic partnership for drug discovery data management.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Collaborative Drug Discovery competitors and assessment

Company assessment

Peers

Direct peers

  • Benchling: Benchling is the most directly comparable cloud-based R&D platform for life sciences, offering ELN, registration, inventory, and workflow tools for biotech and pharma. CDD explicitly positions against Benchling on cost and time-to-value, and the two compete head-to-head for mid-market and enterprise biotech informatics contracts.
  • Dotmatics: Dotmatics (now part of Revvity) is a scientific informatics platform providing ELN, registration, assay analysis, and data visualization for drug discovery. Like CDD, it serves chemistry and biology workflows for pharma and biotech, and is cited by CDD as a direct competitor on cost and ease-of-use dimensions.
  • IDBS: IDBS (owned by Danaher) provides the Polar and E-WorkBook ELN platforms for biopharmaceutical R&D, with deep history in process and formulation data. It competes with CDD for biotech informatics spend, particularly with larger pharma customers and process development workflows.
  • LabArchives: LabArchives is a SaaS ELN widely used in academic and research institutions, including many NIH-funded groups that CDD also serves. It competes with CDD's ELN module, particularly in academic settings where budget and NIH DMS Policy compliance drive platform choice.
  • LabVantage: LabVantage is a LIMS/ELN provider serving pharmaceutical, biotech, and academic labs with sample tracking and laboratory workflow management. It competes with CDD Vault's inventory and assay management modules for lab informatics contracts.
  • Mestrelab Research: Mestrelab provides chemistry-focused informatics software including Mnova for NMR/LC-MS analysis and chemical registration tools. It overlaps with CDD's chemistry registration and assay analysis capabilities, particularly for medicinal chemistry customers.
  • ChemAxon: ChemAxon provides cheminformatics software (JChem, Marvin, Compound Registration) for chemical structure management, search, and analysis. It serves similar drug discovery and chemistry R&D customers as CDD and competes on chemical registration and structure-based data management.

Market position

Strengths5 records

Weaknesses1 record

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Collaborative Drug Discovery social profiles

Digital presence

Collaborative Drug Discovery compliance and trust

Trust signal

Compliance3 records

Collaborative Drug Discovery financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Collaborative Drug Discovery leadership team

Management profile

Number of profiles

Profiles2 records

Collaborative Drug Discovery funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Collaborative Drug Discovery M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Collaborative Drug Discovery

What does Collaborative Drug Discovery do?

Collaborative Drug Discovery (CDD) sells CDD Vault, a hosted, web-based scientific data management platform and electronic lab notebook (ELN) purpose-built for drug discovery research. The platform securely registers and tracks chemical and biological entities (small molecules, biologics, peptides, nucleic acids, mixtures), captures experimental assay and activity data, and enables real-time collaboration across organizations. Modular add-ons extend capabilities into ELN, inventory management, dose-response curve fitting, AI/ML-driven lead discovery, and laboratory automation integrations.

Is Collaborative Drug Discovery a public or private company?

Collaborative Drug Discovery is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Collaborative Drug Discovery founded?

Collaborative Drug Discovery was founded in 2004. It employs 51 to 100 people.

Where is Collaborative Drug Discovery based?

Collaborative Drug Discovery is headquartered in Burlingame, United States, in the North America region.

How does Collaborative Drug Discovery make money?

One revenue line is on record: software Subscription (CDD Vault).

Who are Collaborative Drug Discovery's main competitors?

BIOVIA (Dassault Systèmes) is listed as a peer. Direct peers are Benchling, Dotmatics, IDBS, LabArchives, LabVantage, Mestrelab Research and ChemAxon.

Does Collaborative Drug Discovery have an API?

Yes. CDD Vault provides a REST API that allows programmatic access to assay results and other platform data. Assay results for published resources are accessible via REST API using standard HTTPS calls with authentication tokens. Users can ingest outputs from core facilities and bench instruments with minimal manual wrangling through API integration. Developer documentation is at support.collaborativedrug.com/hc/en-us/categories/115001259423-API-Documentation.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
BiotechniquesDriving innovation in lab automation and life sciences at SLAS Europe 2026The Society for Laboratory Automation and Screening (SLAS) held its 2026 European Conference and Exhibition in Vienna, Austria, with over 1,500 registrants from more than 30 countries and 137 exhibitors. Multiple companies launched new products including Omega Bio-tek, Bionomous, Cenevo, and Lutèce Dynamics, while award winners included Bionomous, Cube Biotech, and nNano AG for innovative lab automation solutions. Strategic partnerships were announced, including one between Cerillo Bio and Hamilton Company and another between Collaborative Drug Discovery and Lilly TuneLab, reflecting the industry's shift toward integrated, high-precision workflows and AI-enabled drug discovery platforms.EIN PresswireCDD Vault and Kiin Bio Integrate to Streamline End-to-End Drug Discovery WorkflowsCDD Vault and Kiin Bio announced a partnership integrating KiinOS with CDD Vault, allowing researchers to connect pre-clinical discovery data directly into KiinOS workflows. CDD Vault hosts over 4 billion experimentally-validated data points and is trusted by more than 750 biotech and pharma companies.GenengnewsBio-IT World Keynote Highlights Collaborative Intelligence in AI-Driven Drug DiscoveryA keynote panel at the Bio-IT World Conference 2026 in Boston brought together scientists and industry leaders to discuss the role of foundation models and federated learning in AI-driven drug discovery, highlighting the open-source OpenFold Consortium as a community-driven alternative to AlphaFold. Eli Lilly presented its TuneLab platform, launched in 2025, which provides AI/ML models to biotech partners at no cost and has grown to over 75 partners across dozens of countries, while also announcing a new integration agreement with Collaborative Drug Discovery to embed TuneLab into the CDD Vault platform. Speakers from Apheris, SandboxAQ, and Bayer underscored the importance of federated learning for leveraging proprietary biopharma data and fine-tuning models for practical drug discovery applications.Scientist LivePartnership to accelerate drug developmentPharmaceutical company Eli Lilly has partnered with Collaborative Drug Discovery to integrate its AI/ML drug discovery platform TuneLab into CDD Vault software. The integration allows biotechnology companies using CDD Vault to access Lilly's predictive ADMET models trained on decades of research data for in silico property predictions across small molecules and antibody therapeutics. The federated training approach means model accuracy will improve as more companies contribute data within the secure CDD Vault environment.GenengnewsCollaborative Drug Discovery Inks Deal with Eli Lilly to Accelerate Biotech InnovationCollaborative Drug Discovery (CDD) has signed an agreement with Eli Lilly to integrate Lilly's TuneLab predictive models into CDD's Vault software platform, enabling biotech companies using CDD Vault to access Lilly's ADMET models trained on proprietary research data. The partnership advances CDD's founding vision of web-based collaboration in drug discovery and will be integrated into both core and AI modules within CDD Vault for participating companies.YahooCollaborative Drug Discovery Partners with Lilly TuneLab to Make Lilly AI/ML Models Available in CDD VaultCollaborative Drug Discovery (CDD) announced a partnership with Eli Lilly to integrate Lilly's TuneLab AI/ML drug discovery platform into CDD Vault, enabling biotech companies using CDD Vault to access select Lilly predictive models trained on decades of proprietary research data. The integration will be available within both core and AI modules of CDD Vault for participating biotech companies. CDD CEO Barry Bunin stated that the partnership advances CDD's core vision of enabling collaboration across drug discovery teams and organizations.PR NewswireCollaborative Drug Discovery Partners with Lilly TuneLab to Make Lilly AI/ML Models Available in CDD VaultCollaborative Drug Discovery (CDD) announced a partnership with Eli Lilly to integrate Lilly TuneLab, an AI/ML drug discovery platform, into CDD Vault, enabling biotech companies to access Lilly's predictive models trained on decades of proprietary research data. The integration will be available in both core and AI modules within CDD Vault for biotech companies that opt into the program, advancing CDD's vision of enabling cross-organizational collaboration in drug discovery. This agreement builds on CDD's founding mission from 2004 to demonstrate the economics of efficiency of web-based collaboration.GenengnewsWhy Data Infrastructure Determines AI Success in Drug DiscoveryThis industry perspective article examines why AI models in drug discovery often underperform due to data quality and infrastructure challenges rather than algorithmic limitations, outlining three interconnected requirements: capturing molecular complexity in machine-readable formats, implementing FAIR data principles at scale, and building collaboration-centric platforms. It emphasizes that biologics such as antibody-drug conjugates require atomic-level chemical representation beyond traditional sequence notation, and that regulatory compliance requirements align with AI best practices for data architecture. The article suggests organizations investing in robust data foundations now will be better positioned for future computational advances in pharmaceutical R&D.openPR.comDrug Discovery Informatics Market Outlook 2025-2032: AI-Driven Platforms Accelerating Next-Generation Drug DevelopmentThe drug discovery informatics market reached approximately US$ 4.98 billion in 2024 and is projected to grow to around US$ 14.25 billion by 2032, with a compound annual growth rate of 15.2% during the forecast period 2025–2032, driven by increasing adoption of AI, machine learning, and advanced data analytics to accelerate drug discovery and reduce development costs. North America held the largest regional market share at 41%, supported by strong life sciences research infrastructure and early adoption by major pharmaceutical companies, while Asia-Pacific is expected to witness the fastest growth due to rising biotech activity and expanding contract research organizations. Key players in the market include Certara (22.6% share), Charles River Laboratories (18.9%), and Collaborative Drug Discovery, Inc. (12.4%).CollaborativedrugIBRI Case StudyThe Indiana Biosciences Research Institute (IBRI) has deployed an integrated drug discovery informatics platform combining Collaborative Drug Discovery's CDD Vault and Schrödinger's LiveDesign to accelerate research. This solution enables the seamless management of biological and chemical data while supporting computational modeling and the full Design-Make-Test-Analyze cycle for scientists and partners. The integration aims to streamline workflows, ensure data consistency, and improve collaboration across academic and industry teams.